Healthcare Industry News: Paracetamol
News Release - January 20, 2011
Genmed Signs Five Year Deal with Irish Multi-National Pharmaceutical Distributor
AMSTERDAM--(Healthcare Sales & Marketing Network)-- Genmed Holding Corp. (OTCBB:GENM.ob ) has entered into a five year distribution contract with an Irish multi-national pharmaceutical distribution company which maintains one of the largest pharmaceutical distribution networks in the United Kingdom. The agreement between the companies marks the first of its kind for Genmed.While specific details of the agreement cannot be released, Genmed is disclosing that pricing for Genmed’s generic analgesic, Paracetamol, has been agreed upon and deliveries are being scheduled for the 2nd quarter of 2011. The product will be rolled out to the distributor’s network of more than 1,200 pharmacies starting in the 3rd quarter of 2011.
GenMed Chief Executive Officer, Erwin Bouwens said, “This agreement marks a giant milestone for our company. It is an enormous opportunity and lays the framework for other cooperative partnerships we are seeking throughout the EU.”
About Genmed Holding Corp.
Genmed Holding Corp. is a United States and Dutch based company focusing on the delivery of low cost generic pharmaceutical drugs directly to distribution channels throughout the world. The Company began its generic drug business in 2008 and today operates primarily through its 100% owned subsidiary Genmed B.V., which is registered in the Netherlands. The Company is led by an experienced management team and board who have considerable and highly relevant experience in product development, registration, sales, marketing, distribution, operations, and financial administration.
For Additional Information, Go to the Website: www.genmed.nl
This press release contains certain "forward-looking statements" within the meaning of federal securities laws including the use of the words "expect," "anticipate," "estimate," "project," "forecast," "outlook," "target," "objective," "plan," "goal," "pursue," "on track," and similar expressions. Although the Company believes that the statements were reasonable when made, these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements of the company to be different from those expressed or implied. The Company assumes no obligation and does not intend to update these forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: competitive and general economic conditions, adverse effects of litigation, the timely development and acceptance of our products and services, significant changes in the competitive environment, the failure to generate or the loss of significant numbers of customers, the loss of senior management or increased government regulation.
Source: Genmed
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!